" /> Facioscapulohumeral muscular dystrophy 1 - CISMeF





Preferred Label : Facioscapulohumeral muscular dystrophy 1;

Symbol : FSHD1;

CISMeF acronym : FMD; FSHD; FSHD1A; FSHD1;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Muscular dystrophy, facioscapulohumeral, type 1; Facioscapulohumeral muscular dystrophy; Muscular dystrophy, facioscapulohumeral, type 1a; Landouzy-dejerine muscular dystrophy; FSHD; FMD; FSHD1A;

Included titles and symbols : Facioscapulohumeral muscular dystrophy, infantile; Facioscapulohumeral dystrophy with sensorineural hearing loss and tortuosity of retinal arterioles;

Description : Facioscapulohumeral muscular dystrophy is the third most common hereditary disease of muscle after Duchenne (DMD; 310200) and myotonic (160900) dystrophy. It is a highly variable disorder with weakness appearing from infancy to late life but typically in the second decade. In general, the disease initially involves the face and the scapulae followed by the foot dorsiflexors and the hip girdles. Typical features are striking asymmetry of muscle involvement from side to side and sparing of bulbar extraocular and respiratory muscles (Tawil et al., 1998). Richards et al. (2012) provided a detailed review of FSHD. See also FSHD2 (158901), which is phenotypically indistinguishable from;

Inheritance : Autosomal dominant;

Molecular basis : Caused by contraction of a D4Z4 repeat array at chromosome 4q35;

Laboratory abnormalities : Increased serum creatine kinase;

Prefixed ID : #158900;

Details


You can consult :


Nous contacter.
26/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.